Published in J Neurochem on January 09, 2006
How citation distortions create unfounded authority: analysis of a citation network. BMJ (2009) 3.66
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A (2006) 1.11
Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol (2011) 1.01
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. Eur J Pharmacol (2010) 0.95
Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats. Eur J Pharmacol (2011) 0.92
Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity. J Obes (2010) 0.89
Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther (2011) 0.85
Hereditary Inclusion Body Myopathy (HIBM2). Gene Regul Syst Bio (2009) 0.82
Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy. Biomark Med (2014) 0.76
Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model. Sci Rep (2016) 0.75
Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity. J Clin Invest (2017) 0.75
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol (2007) 5.50
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J (2009) 2.22
Rectovaginal fistula after double-stapled transanal rectotomy (STARR) for obstructed defaecation. Int J Colorectal Dis (2004) 2.19
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain (2003) 2.11
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J (2007) 1.92
An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet (2012) 1.88
Results, outcome predictors, and complications after stapled transanal rectal resection for obstructed defecation. Dis Colon Rectum (2007) 1.87
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol (2010) 1.80
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A (2008) 1.80
Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol (2004) 1.77
Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet (2012) 1.75
Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol (2003) 1.72
Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol (2005) 1.46
Motor cortex stimulation for amyotrophic lateral sclerosis. Time for a therapeutic trial? Clin Neurophysiol (2004) 1.42
Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson's disease. Exp Neurol (2004) 1.34
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci U S A (2002) 1.24
Long-term outcome of Altemeier's procedure for rectal prolapse. Dis Colon Rectum (2009) 1.23
Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol (2004) 1.22
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain (2011) 1.17
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet (2011) 1.16
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol (2010) 1.16
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res (2006) 1.15
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. Muscle Nerve (2010) 1.15
Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. Hum Mutat (2004) 1.14
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A (2006) 1.11
GABAA receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol (2006) 1.10
Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol (2005) 1.09
Pilot trial of phenylbutyrate in spinal muscular atrophy. Neuromuscul Disord (2004) 1.08
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol (2003) 1.06
The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One (2008) 1.05
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain (2013) 1.05
New phenotype and pathology features in MYH7-related distal myopathy. Neuromuscul Disord (2012) 1.03
Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells (2007) 1.02
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Int J Oncol (2004) 1.01
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine (2008) 1.01
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One (2012) 1.00
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies. J Neurol (2013) 0.99
Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord (2004) 0.99
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene. Muscle Nerve (2008) 0.98
Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol (2006) 0.98
Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J (2003) 0.98
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.97
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol (2007) 0.96
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy. Clin Immunol (2005) 0.95
Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients. J Neuropathol Exp Neurol (2013) 0.95
Quality of life and pain in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve (2009) 0.94
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. J Neurochem (2007) 0.93
Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up. J Inherit Metab Dis (2010) 0.93
The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure. BMC Med Genet (2007) 0.92
Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency. Mol Cell Neurosci (2005) 0.92
Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol (2003) 0.92
MRI anatomy of the anal region. Dis Colon Rectum (2010) 0.92
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy. Muscle Nerve (2009) 0.91
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. Neuropathol Appl Neurobiol (2014) 0.90
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients. Hum Immunol (2010) 0.90
Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscul Disord (2002) 0.90
Gene expression profile of adult human olfactory bulb and embryonic neural stem cell suggests distinct signaling pathways and epigenetic control. PLoS One (2012) 0.90
Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. PLoS One (2011) 0.90
Muscle imaging findings in GNE myopathy. J Neurol (2012) 0.90
Anal continence after rectocele repair. Dis Colon Rectum (2002) 0.90
Persistent effects of high frequency repetitive TMS on the coupling between motor areas in the human. Exp Brain Res (2002) 0.89
Investigating the neurobiology of music: brain-derived neurotrophic factor modulation in the hippocampus of young adult mice. Behav Pharmacol (2007) 0.89
Hippocampal magnetic resonance imaging abnormalities in transient global amnesia. Arch Neurol (2005) 0.89
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord (2011) 0.89
Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci (2009) 0.89
Down-regulation of inflammation-protective microRNAs 146a and 212 in monocytes of patients with postpartum psychosis. Brain Behav Immun (2013) 0.88